Reprogramming Tumor‐Associated Neutrophils to Enhance Radio‐Immunotherapy
Advanced Materials · 2026-05 · 38 (26)
DOI: 10.1002/adma.73042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 10.04.2026. Verfasst von Xulu Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and P…. Hauptthemen laut MEDLINE: Neutrophils, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Social Development of Jiangsu Province, Natural Science Foundation of the Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
As central effector cells in innate immunity, neutrophils are rapidly recruited to tumors following radiotherapy (RT). However, their frequent polarization toward the pro‐tumor N2 phenotype and the formation of metastasis‐promoting neutrophil extracellular traps (NETs) significantly limit treatment outcomes. To reprogram these RT‐recruited tumor‐associated neutrophils (TANs), we develop injectable hydrogel microspheres (HMPs) co‐loaded with a TLR4 agonist (lipopolysaccharide) and a PAD4 inhibitor (GSK484). The resulting L/G@HMPs effectively redirect TAN polarization toward the anti‐tumor N1 phenotype, inhibit NET formation, and extend neutrophil lifespan beyond 72 h. In murine tumor models, the combination of RT and L/G@HMPs triggers robust innate and adaptive immune responses, marked by substantial accumulation of N1‐polarized TANs and CD8 + T cells within tumors, leading to potent tumor eradication. This study presents a hydrogel‐based strategy that concurrently modulates neutrophil lifespan, phenotype, and NETs, thereby transforming tumor‐promoting neutrophils into anti‐tumor allies for enhanced radio‐immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RA…
- Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, Jiangsu, China.
ORCID-Profile: Kai Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Social Development of Jiangsu Province
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Jiangsu Province Seventh 333 High Level
- Talents Project, Suzhou Fundamental Research Project
- Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University
Zitieren
APA
Yang, X., Lang, S., Liu, T., Zhao, X., Yan, Y., Zhang, Y., Feng, L., Liu, T., & Yang, K. (2026). Reprogramming Tumor‐Associated Neutrophils to Enhance Radio‐Immunotherapy. Advanced Materials, 38(26). https://doi.org/10.1002/adma.73042
Vancouver
Yang X, Lang S, Liu T, Zhao X, Yan Y, Zhang Y, et al. Reprogramming Tumor‐Associated Neutrophils to Enhance Radio‐Immunotherapy. Advanced Materials. 2026;38(26). doi:10.1002/adma.73042
BibTeX
@article{Yang2026,
author = {Yang, Xulu and Lang, Shanshan and Liu, Tongtong and Zhao, Xin and Yan, Yifan and Zhang, Yanxiang and Feng, Liangzhu and Liu, Teng and Yang, Kai},
title = {Reprogramming Tumor‐Associated Neutrophils to Enhance Radio‐Immunotherapy},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {26},
doi = {10.1002/adma.73042}
}
EUVIMED